Download FREE Report Sample
Download Free sampleThe global Insulin Glargine market was valued at 594.3 Million USD in 2021 and will grow with a CAGR of 3.82% from 2021 to 2027, based on Research newly published report.
The prime objective of Insulin Glargine Market is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, Insulin Glargine Market covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).Insulin glargine is a long-acting, man-made version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is Used for energy. It also stops the liver from producing more sugar. There are two type of Insulin glargine, which are Single Dose Vial and Pre-filled Syringe in the market. Considering its function, Insulin glargine is Used to treat Single Dose Vial diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also Used to treat people with Pre-filled Syringe diabetes (condition in which the body does not Used insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes. We can see that there are just a few companies produce Insulin glargine, the production of them almost approach to 70% of whole market. They have seted plant in Japan, China, German, India, North Americato produce Insulin glargine, and China is the largest plant for Insulin glargine in the world and also the largest consumption country. As the amount of diabetes of increasing of China, the Chinese market will be bigger than North America. The Industry is affected by the economic development level and policy, so it`s important to put an eye to economic indexes and leaders` prefer. With the global economic recovery, more and more people pay attention to care about personal health, especially in underdevelopment regions that have a large population and fast economic growth, the need of Insulin glargine will increase.
By Market Verdors:
By Types:
By Applications:
Key Indicators Analysed
Key Reasons to Purchase
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy